(精选)【医学课件课件】糖尿病患之高血壓症教学课件.pptVIP

糖尿病患之高血壓症;Diabetes and Hypertension;高血壓病患有較高的糖尿病發生率;高血糖值增加高血壓之風險;高血壓糖尿病主要併發症之風險;糖尿病與收縮高血壓症：增加心血管病風險;高血壓在糖尿病病患的重要性;降低血壓有助減低糖尿病相關併發症之風險;糖尿病患血壓目標值之實證;高血壓病患非藥物治療之實證 (一);高血壓病患非藥物治療之實證 (二);Study;SHEP研究中283位併單獨收縮高血壓之糖尿病患以Diuretic治療之效果;UKPDS BP Control Study:Tight vs Less Tight Control;0.2;Blood pressure (mm Hg); ;以血管張力素轉化酵素抑制劑治療高血壓之糖尿病患的效果;Effects of ACEI on BP in Hypertensive Type 2 Diabetics with Incipient Nephropathy BRILLIANT;;ACEI Improves Albumin Excretion Rate in Microalbuminuric Patients with T1DM ： EUrodiab Controlled trial of Lisinopril in Insulin dependent Diabetes (EUCLID) ;Malaise and fatigue Edema GI tract Diseases Renal Failure Cough Erectile dysfunction Headache Depression Rash Allergic reaction Intermittent claudication Bronchospasm Cold and numb hand Hypokalemia Hyponatremia) ;;Nephroprotective Role of Angiotensin II Receptor Antagonists in Type 2 Diabetes;The Effect of Irbesartan on The Development of Diabetic Nephropathy in Patients with T2DM ;糖尿病病患併高血壓之藥物治療實證 (甲);All patients with DM and HTN should be treated with a regimen that includes either an ACEI or ARB. If one class is not tolerated, the other should be substituted. If needed to achieve blood pressure targets, a thiazide diuretic should be added. (E) If ACE inhibitors or ARBs are used, monitor renal function and serum potassium levels. (E) There is clinical trial support for each of the following statements: In patients with type 1 diabetes with hypertension and any degree of albuminuria, ACE inhibitors have been shown to delay the progression of nephropathy. (A) In patients with type 2 diabetes, hypertension, and microalbuminuria, ACE inhibitors and ARBs have been shown to delay the progression to macroalbuminuria. (A) In those with type 2 diabetes, hypertension, macroalbuminuria (300 mg/day), and renal insufficiency, an ARB should be strongly considered. (A) ;0.5;ARB and Renal Disease in Patients With Type 2